×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VYNE – vyne therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VYNE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/20
08:06 am
vyne
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference [Yahoo! Finance]
Medium
Report
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference [Yahoo! Finance]
3/20
08:00 am
vyne
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
Medium
Report
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
3/6
02:24 pm
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Low
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
3/6
08:00 am
vyne
VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update
Low
Report
VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update
2/20
08:00 am
vyne
VYNE Therapeutics to Participate in March Investor Conferences
Medium
Report
VYNE Therapeutics to Participate in March Investor Conferences
2/19
11:22 am
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Medium
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
2/19
08:00 am
vyne
VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis
Low
Report
VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis
1/14
08:02 am
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Medium
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
4/2
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Harsch Mutya
Low
Report
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Harsch Mutya
4/2
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Stuart Iain
Low
Report
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Stuart Iain
4/2
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Domzalski David
Low
Report
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Domzalski David
4/2
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Zeronda Tyler
Low
Report
Form 4 VYNE Therapeutics Inc. For: Mar 31 Filed by: Zeronda Tyler
3/6
04:03 pm
vyne
Form 10-K VYNE Therapeutics Inc. For: Dec 31
Medium
Report
Form 10-K VYNE Therapeutics Inc. For: Dec 31
3/6
08:06 am
vyne
Form 8-K VYNE Therapeutics Inc. For: Mar 06
Low
Report
Form 8-K VYNE Therapeutics Inc. For: Mar 06
1/23
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Jan 21 Filed by: Harsch Mutya
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Jan 21 Filed by: Harsch Mutya
1/23
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Jan 21 Filed by: Stuart Iain
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Jan 21 Filed by: Stuart Iain
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: